Molecular basis of Canavan's disease: From human to mouse

Sankar Surendran, Kimberlee M. Matalon, Stephen K. Tyring, Reuben Matalon

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Canavan's disease is an autosomal recessive disorder caused by aspartoacylase deficiency. The deficiency of aspartoacylase leads to increased concentration of N-acetylaspartic acid in brain and body fluids. The failure to hydrolyze N-acetylaspartic acid causes disruption of myelin, resulting in spongy degeneration of the white matter of the brain. The clinical features of the disease are hypotonia in early life, which changes to spasticity, macrocephaly, head lag, and progressive severe mental retardation. Although Canavan's disease is panethnic, it is most prevalent in the Ashkenazi Jewish population. Research at the molecular level led to the cloning of the gene for aspartoacylase and development of a knockout mouse for Canavan's disease. These developments have afforded new tools for research in the attempts to understand the pathophysiology of Canavan's disease, design new therapies, and explore methods for gene transfer to the central nervous system.

Original languageEnglish (US)
Pages (from-to)604-610
Number of pages7
JournalJournal of Child Neurology
Volume18
Issue number9
StatePublished - Sep 1 2003

Fingerprint

Canavan Disease
Megalencephaly
Muscle Hypotonia
Brain
Body Fluids
Myelin Sheath
Research
Knockout Mice
Intellectual Disability
Genes
Organism Cloning
Central Nervous System
Head

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Surendran, S., Matalon, K. M., Tyring, S. K., & Matalon, R. (2003). Molecular basis of Canavan's disease: From human to mouse. Journal of Child Neurology, 18(9), 604-610.

Molecular basis of Canavan's disease : From human to mouse. / Surendran, Sankar; Matalon, Kimberlee M.; Tyring, Stephen K.; Matalon, Reuben.

In: Journal of Child Neurology, Vol. 18, No. 9, 01.09.2003, p. 604-610.

Research output: Contribution to journalArticle

Surendran, S, Matalon, KM, Tyring, SK & Matalon, R 2003, 'Molecular basis of Canavan's disease: From human to mouse', Journal of Child Neurology, vol. 18, no. 9, pp. 604-610.
Surendran S, Matalon KM, Tyring SK, Matalon R. Molecular basis of Canavan's disease: From human to mouse. Journal of Child Neurology. 2003 Sep 1;18(9):604-610.
Surendran, Sankar ; Matalon, Kimberlee M. ; Tyring, Stephen K. ; Matalon, Reuben. / Molecular basis of Canavan's disease : From human to mouse. In: Journal of Child Neurology. 2003 ; Vol. 18, No. 9. pp. 604-610.
@article{8affe324507c490395f6029ef4276657,
title = "Molecular basis of Canavan's disease: From human to mouse",
abstract = "Canavan's disease is an autosomal recessive disorder caused by aspartoacylase deficiency. The deficiency of aspartoacylase leads to increased concentration of N-acetylaspartic acid in brain and body fluids. The failure to hydrolyze N-acetylaspartic acid causes disruption of myelin, resulting in spongy degeneration of the white matter of the brain. The clinical features of the disease are hypotonia in early life, which changes to spasticity, macrocephaly, head lag, and progressive severe mental retardation. Although Canavan's disease is panethnic, it is most prevalent in the Ashkenazi Jewish population. Research at the molecular level led to the cloning of the gene for aspartoacylase and development of a knockout mouse for Canavan's disease. These developments have afforded new tools for research in the attempts to understand the pathophysiology of Canavan's disease, design new therapies, and explore methods for gene transfer to the central nervous system.",
author = "Sankar Surendran and Matalon, {Kimberlee M.} and Tyring, {Stephen K.} and Reuben Matalon",
year = "2003",
month = "9",
day = "1",
language = "English (US)",
volume = "18",
pages = "604--610",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "9",

}

TY - JOUR

T1 - Molecular basis of Canavan's disease

T2 - From human to mouse

AU - Surendran, Sankar

AU - Matalon, Kimberlee M.

AU - Tyring, Stephen K.

AU - Matalon, Reuben

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Canavan's disease is an autosomal recessive disorder caused by aspartoacylase deficiency. The deficiency of aspartoacylase leads to increased concentration of N-acetylaspartic acid in brain and body fluids. The failure to hydrolyze N-acetylaspartic acid causes disruption of myelin, resulting in spongy degeneration of the white matter of the brain. The clinical features of the disease are hypotonia in early life, which changes to spasticity, macrocephaly, head lag, and progressive severe mental retardation. Although Canavan's disease is panethnic, it is most prevalent in the Ashkenazi Jewish population. Research at the molecular level led to the cloning of the gene for aspartoacylase and development of a knockout mouse for Canavan's disease. These developments have afforded new tools for research in the attempts to understand the pathophysiology of Canavan's disease, design new therapies, and explore methods for gene transfer to the central nervous system.

AB - Canavan's disease is an autosomal recessive disorder caused by aspartoacylase deficiency. The deficiency of aspartoacylase leads to increased concentration of N-acetylaspartic acid in brain and body fluids. The failure to hydrolyze N-acetylaspartic acid causes disruption of myelin, resulting in spongy degeneration of the white matter of the brain. The clinical features of the disease are hypotonia in early life, which changes to spasticity, macrocephaly, head lag, and progressive severe mental retardation. Although Canavan's disease is panethnic, it is most prevalent in the Ashkenazi Jewish population. Research at the molecular level led to the cloning of the gene for aspartoacylase and development of a knockout mouse for Canavan's disease. These developments have afforded new tools for research in the attempts to understand the pathophysiology of Canavan's disease, design new therapies, and explore methods for gene transfer to the central nervous system.

UR - http://www.scopus.com/inward/record.url?scp=0141893608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141893608&partnerID=8YFLogxK

M3 - Article

C2 - 14572138

AN - SCOPUS:0141893608

VL - 18

SP - 604

EP - 610

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 9

ER -